OTC:HEPA | Free Cash Flow | Hepion Pharmaceuticals, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2013-09-30 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31$578,584.00
2025-12-31-$332,775.00
2025-03-31-$1.12M
2024-12-31-$1.15M
2024-03-31-$3.62M
2023-12-31-$9M$348.00-$9M
2023-03-31-$8.21M$0.00-$8.21M
2022-12-31-$4.8M$16,336.00-$4.81M
2022-03-31-$10.13M$0.00-$10.13M
2021-12-31-$7.38M-$1.00-$7.38M
2021-03-31-$7.35M$82,105.00-$7.43M
2020-12-31-$4.53M$76,546.00-$4.6M
2020-03-31-$4.68M$0.00-$4.68M
2019-12-31-$2.44M$6,133.00-$2.45M
2019-03-31-$2.06M$37,849.00-$2.1M
2018-12-31-$5.09M
2018-03-31-$3.59M
2017-09-30-$5.37M
2017-06-30-$4.25M$2,425.00-$4.25M-207.39%
2017-03-31-$5.22M
2016-09-30-$4.38M
2016-06-30-$4.4M$0.00-$4.4M
2015-09-30-$2.8M$6,603.00-$2.81M
2015-06-30-$4.34M$0.00-$4.34M
2014-09-30-$1.04M$43,795.00-$1.08M
2014-06-30-$692,439.00$0.00-$692,439.00-15.81%
2013-09-30-$110,712.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$3.27M
2024-12-31-$18.22M
2023-12-31-$40.89M$14,304.00-$40.9M
2022-12-31-$34.96M$16,336.00-$34.98M
2021-12-31-$31.22M$130,405.00-$31.35M
2020-12-31-$16.17M$87,983.00-$16.25M
2019-12-31-$7.57M$51,469.00-$7.62M
2018-12-31-$15.65M
2017-06-30-$19.17M$14,709.00-$19.19M
2016-06-30-$16.56M$6,603.00-$16.56M
2015-06-30-$9.67M$83,269.00-$9.76M
2014-06-30-$1.36M$15,847.00-$1.38M